TGFB1 and depressive disorder: Duloxetine was reported to possess anti-inflammatory (decreasing TGF-β proteins) and antioxidant properties to regulate the expression of angiogenesis and neurotrophic factors [40], which may relate to neuroinflammation and the broader immunological mechanisms underlying depression.